A gathering this week in Atlanta sponsored by the Autism Society of America, ``2000 National Conference on Autism: Celebrating Our Future,'' is focusing on treatment options, research and the incidence of autism.
When news broke a few months ago that Seattle would become one of two places in the country doing federally funded research on an experimental treatment for autism, the researchers were deluged with calls.
Eric London, vice president of medical affairs at the National Alliance for Autism Research in Princeton and a consultant for the investigation.
Eric London, vice president of medical affairs for the National Alliance for Autism Research in Princeton, which funds autism research.
Marie Bristol-Power, who coordinates autism research at the National Institute of Child Health and Human Development in Bethesda, Md.
The UW, which has one of the largest autism research programs in the country, currently has several long-term studies under way looking at how brain structure and activity correlates with the development of autistic traits.
Autism was previously thought to affect one in 500 people, but the number is actually closer to one in 250, according to a study by the Centers for Disease Control and Prevention.
The findings, reported Wednesday at a San Diego meeting of the American Academy of Neurology, could lead to better treatment for patients and new ways to prevent the disorders, Harris said.
Q: What are some of the treatments?
